OA-770 Treatment outcomes of low-level viremia among adults living with HIV on dolutegravir-based first line antiretroviral therapy in Botswana
OT Bareng, S Moyo, M Mudanga, K Sebina… - 2023 - gh.bmj.com
Background We evaluated the treatment outcomes of individuals experiencing low-level
viremia (LLV) on dolutegravir (DTG) based first-line antiretroviral therapy (ART) in Botswana …
viremia (LLV) on dolutegravir (DTG) based first-line antiretroviral therapy (ART) in Botswana …
[PDF][PDF] OA-770 TREATMENT OUTCOMES OF LOW-LEVEL VIREMIA AMONG ADULTS LIVING WITH HIV ON DOLUTEGRAVIR-BASED FIRST LINE …
VCDIDONED SAVE - BMJ, 2023 - researchgate.net
Background We evaluated the treatment outcomes of individuals experiencing low-level
viremia (LLV) on dolutegravir (DTG) based first-line antiretroviral therapy (ART) in Botswana …
viremia (LLV) on dolutegravir (DTG) based first-line antiretroviral therapy (ART) in Botswana …